Data Platform Engineer

We at Glaxo Smith Kline are looking for a highly motivated and experienced Data Platform Engineer to join our team. In this role, you will be responsible for developing and maintaining our data platform, and ensuring the accuracy, integrity and security of the data.The ideal candidate for this position will have a proven track record of success in designing, building, and operating data platforms. You should possess a deep understanding of data engineering principles and best practices, as well as extensive experience with database technologies and tools.Our ideal Data Platform Engineer will be a self-starter, highly organized, and able to work in a fast-paced environment. You should have strong analytical skills and the ability to think strategically. You should also have excellent communication and interpersonal skills, and be able to collaborate effectively with team members and stakeholders.To be successful in this role, you should have:• A Bachelor’s degree in Computer Science, Information Systems, or a related field• At least 5 years of experience in data engineering and platform development• Advanced knowledge of database technologies, such as Postgres, SQL Server, and Oracle• Experience with big data technologies, such as Hadoop, Spark, and Kafka• Knowledge of cloud technologies, such as AWS and Azure• Strong problem-solving and analytical skills• Excellent communication and interpersonal skillsIf this sounds like the right opportunity for you, we invite you to apply and join our team!

According to JobzMall, the average salary range for a Data Platform Engineer in Collegeville, PA 19426, USA is $87,000 to $117,000 per year. This range is based on the salaries reported by current and former employees.

GlaxoSmithKline plc is a British multinational pharmaceutical company headquartered in Brentford, London. Established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, GSK was the world's sixth largest pharmaceutical company as of 2015, after Pfizer, Novartis, Merck, Hoffmann-La Roche and Sanofi.